Dasatinib is a specialist drug that has recently seen success in acting as a senolytic – an agent that removes senescent (dead) cells from the body during the process of autophagy. This process is important as it helps the body to regenerate new and healthy cells, replacing those damaged or lost, and has great bearing on a range of bodily functions including skin health, energy levels and weight control.
Dasatinib is also currently approved as a cancer medication in various countries including the UK and US.
